The Role of Oral Ascorbic Acid Administration in Combination With IV N-acetylcysteine in Delaying Inflammatory Cascade in Sepsis: A Case Report
- PMID: 38169912
- PMCID: PMC10758580
- DOI: 10.7759/cureus.49868
The Role of Oral Ascorbic Acid Administration in Combination With IV N-acetylcysteine in Delaying Inflammatory Cascade in Sepsis: A Case Report
Abstract
Sepsis is a life-threatening emergency that arises owing to a dysregulated host response to infection, leading to existence organ dysfunction. Vitamin C administration has led to a lower mortality rate in sepsis. N-acetylcysteine (NAC) treatment during sepsis improves hepatic function and enhances tissue oxygenation. The objective of this case report is to investigate the synergistic effect of the combination of vitamin C, thiamine, and NAC in delaying sepsis cascade and prolongation of survival time. In this case report, an oral dose of vitamin C 500 mg three times daily in combination with IV thiamine 100 mg three times daily, IV NAC, and hydrocortisone stress dose resulted in 12 days of survival of an immunocompromised patient with ventilator-associated pneumonia on single anti-pseudomonas beta-lactam antibiotic. The patient was a 60-year-old Malay female with previous bone marrow transplantation surgery and a medical history of ischemic stroke on phenytoin and valproate therapy. The patient was transferred to a medical ward in Penang General Hospital, Malaysia, due to community-acquired pneumonia. She was on ceftriaxone for five days, then sedated and ventilated in the ICU, with a shift to cefepime for three days, which was then changed to meropenem for nine days until the last day of life. Total anti-pseudomonas coverage was 12 days. The patient had multiple comorbidities from phenytoin-induced hepatic encephalopathy, acute kidney injury, and three sessions of hemodialysis. IV vitamin C was not available, so an oral dose was administered with potential efficacy in delaying the sepsis inflammatory cascade, leading to the use of a single (not double) anti-pseudomonas antibiotic for 12 days. Prolonged survival duration may be expected in the case of normal bone marrow patients with ventilator-associated pneumonia sepsis. In conclusion, Vitamin C, thiamine, and NAC combination resulted in delayed sepsis progression for 12 days and the survival of the immunocompromised patient on a single anti-pseudomonas beta-lactam antibiotic.
Keywords: ascorbic acid; inflammatory cascade; n-acetylcysteine; pneumonia; sepsis.
Copyright © 2023, Abdo et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial.JAMA. 2021 Feb 23;325(8):742-750. doi: 10.1001/jama.2020.24505. JAMA. 2021. PMID: 33620405 Free PMC article. Clinical Trial.
-
Vitamin C and Thiamine for Sepsis and Septic Shock.Am J Med. 2020 May;133(5):635-638. doi: 10.1016/j.amjmed.2019.07.054. Epub 2019 Aug 28. Am J Med. 2020. PMID: 31469984
-
Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis: The ORANGES Trial.Chest. 2020 Jul;158(1):164-173. doi: 10.1016/j.chest.2020.02.049. Epub 2020 Mar 17. Chest. 2020. PMID: 32194058 Clinical Trial.
-
Vitamin C, Thiamine, and Steroids in the Sepsis Conquest: Replete to Defeat.J Pharm Pract. 2020 Oct;33(5):682-695. doi: 10.1177/0897190019851923. Epub 2019 Jun 25. J Pharm Pract. 2020. PMID: 31238773 Review.
-
Hydrocortisone, Ascorbic Acid and Thiamine (HAT Therapy) for the Treatment of Sepsis. Focus on Ascorbic Acid.Nutrients. 2018 Nov 14;10(11):1762. doi: 10.3390/nu10111762. Nutrients. 2018. PMID: 30441816 Free PMC article. Review.
References
-
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Evans L, Rhodes A, Alhazzani W, et al. https://doi.org/10.1007/s00134-021-06506-y. Intensive Care Med. 2021;47:1181–1247. - PMC - PubMed
-
- The emerging role of vitamin C as a treatment for sepsis. Kashiouris MG, L'Heureux M, Cable CA, Fisher BJ, Leichtle SW, Fowler AA. https://doi.org/10.3390/nu12020292 Nutrients. 2020;12:1–16. - PMC - PubMed
-
- Sepsis and acute respiratory distress syndrome: recent update. Kim WY, Hong SB. https://doi.org/10.4046/trd.2016.79.2.53. Tuberc Respir Dis (Seoul) 2016;79:53–57. - PMC - PubMed
-
- Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals . Rhee C, Jones TM, Hamad Y, et al. https://doi.org/10.1001/jamanetworkopen.2018.7571 JAMA Netw Open. 2019;2:0. - PMC - PubMed
-
- Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Neumann FJ, Marx N, Gawaz M, et al. https://doi.org/10.1161/01.CIR.95.10.2387. Circulation. 1997;95:2387–2394. - PubMed
Publication types
LinkOut - more resources
Full Text Sources